Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer

SIMPLE SUMMARY: Patients with platinum-resistant ovarian cancer experience poor prognosis. No mature evidence supports the routine adoption of immunotherapy alone in this setting. However, the combination of immunotherapy with target therapies seems to be a promising option in patients with ovarian...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Indini, Alice, Nigro, Olga, Lengyel, Csongor György, Ghidini, Michele, Petrillo, Angelica, Lopez, Salvatore, Raspagliesi, Francesco, Trapani, Dario, Khakoo, Shelize, Bogani, Giorgio
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8037571/
https://ncbi.nlm.nih.gov/pubmed/33916221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071663
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados